Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

CD4<sup>+</sup> T cells reactive to Epstein-Barr virus late lytic antigens are enriched in individuals with multiple sclerosis.

Science translational medicine·2026

Same author

Regional patterns of grey matter volume decline in relapsing-remitting multiple sclerosis relative to healthy ageing.

NeuroImage·2026

Same author

Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.

The New England journal of medicine·2026

Same author

Alpha-linolenic acid associations with disability and brain volume in multiple sclerosis: a brief replication report.

Frontiers in neurology·2026

Same author

Low risk of severe COVID-19 in vaccinated people with multiple sclerosis: a nationwide Norwegian study.

BMJ neurology open·2026

Same author

NorTrials drives growth in Norwegian clinical trials.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026

Search research articles

Related Experiment Video

Updated: Jun 22, 2026

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

Antibodies against interferon-beta in multiple sclerosis.

Nina Karin Aarskog¹, Tove Marøy, Kjell-Morten Myhr

¹Department of Neurology, Haukeland University Hospital, N-5021 Bergen, Norway.

Journal of Neuroimmunology

|May 27, 2009

Summary

A significant percentage of multiple sclerosis patients develop binding antibodies (BAB) and neutralizing antibodies (NAB) against interferon-beta (IFN-beta) treatments. Real-time PCR is recommended for routine NAB measurement in these patients.

More Related Videos

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

Related Experiment Videos

Last Updated: Jun 22, 2026

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

Area of Science:

Immunology
Neuroscience
Pharmacology

Background:

Interferon-beta (IFN-beta) is a common treatment for relapsing-remitting multiple sclerosis (RRMS).
The development of antibodies against IFN-beta can impact treatment efficacy.
Monitoring antibody levels is crucial for managing MS patients on IFN-beta therapy.

Purpose of the Study:

To determine the frequency of binding antibodies (BAB) and neutralizing antibodies (NAB) against IFN-beta in RRMS patients.
To compare different methods for detecting NAB against IFN-beta.
To evaluate the clinical utility of real-time PCR for NAB detection.

Main Methods:

Sera from 827 RRMS patients treated with IFN-beta were analyzed for BAB and NAB.
Binding antibody (BAB) levels were measured.
Neutralizing antibody (NAB) detection was performed using MxA protein induction assay (ELISA) and MxA mRNA induction assay (real-time PCR).

Main Results:

43.9% of patients developed BAB after 12 months of IFN-beta treatment.
NAB was detected in 70.8% of BAB-positive sera (31.1% of all patients) using real-time PCR.
Real-time PCR and ELISA showed comparable results for NAB detection, indicating good correlation.

Conclusions:

A substantial proportion of RRMS patients develop antibodies against IFN-beta.
Real-time PCR is a reliable and advantageous method for routine NAB measurement in MS patients on IFN-beta.
Routine monitoring of NAB using real-time PCR can aid in optimizing IFN-beta therapy for MS patients.